Publication & Citation Trends
Publications
20 total
Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD PDF
Cited by 1,237
OpenAlex
Pneumonia Risk with Inhaled Fluticasone Furoate and Vilanterol Compared with Vilanterol Alone in Patients with COPD
Cited by 155
OpenAlex
Once-daily inhaled fluticasone furoate and vilanterol versus vilanterol only for prevention of exacerbations of COPD: two replicate double-blind, parallel-group, randomised controlled trials
Cited by 358
OpenAlex
The Efficacy and Safety of the Novel Long-Acting β2 Agonist Vilanterol in Patients With COPD
Cited by 105
OpenAlex
Cardiovascular Safety of Cilomilast in Patients With Chronic Obstructive Pulmonary Disease (COPD PDF
Cited by 5
OpenAlex
Effect of Cilomilast on Chronic Obstructive Pulmonary Disease (COPD) Patients With Impaired Quality of Life (QOL PDF
Cited by 5
OpenAlex
Cilomilast Reduces Exacerbations in Patients With Chronic Obstructive Pulmonary Disease (COPD
Cited by 5
OpenAlex
Research Topics
Chronic Obstructive Pulmonary Disease (COPD) Research
(17)
Asthma and respiratory diseases
(9)
Inhalation and Respiratory Drug Delivery
(8)
Respiratory Support and Mechanisms
(4)
Respiratory and Cough-Related Research
(4)
Affiliations
Research Triangle Park Foundation
GlaxoSmithKline (United Kingdom)
GlaxoSmithKline (United States)
Glaxosmithkline (Finland)
Pulmonary Associates